ECOG-ACRIN Cancer Research Group

Biomarker-driven medical research involving adults who have or are at risk of developing cancer

[ECOG-ACRIN Cancer Research Group @eaonc]

Do you have #AcuteMyeloidLeukemia (#AML) and are age 60 or older? If so, you may be able to participate in this study of a potential new treatment. Learn more: https://t.co/lqKwON7qZ1 #leukemia #leusm

[ECOG-ACRIN Cancer Research Group @eaonc]

The EAF223/GABLE clinical study is testing different imaging techniques that could help make better predictions about #BrainCancer progression. Learn more here: https://t.co/NJBtg6CQfJ
cc: @DukeRadiology, @glioblastf, @gbmfoundation

[ECOG-ACRIN Cancer Research Group @eaonc]

#FindingsFriday: ICYMI - Adding sTILs to the PREDICT prognostic model may improve identification of low-risk patients with early-stage #TNBC who could potentially avoid chemotherapy. Published in @Annals_Oncology: https://t.co/jO7puZ1OnQ #BreastCancer #bcsm

[ECOG-ACRIN Cancer Research Group @eaonc]

Patients with newly diagnosed #MultipleMyeloma may be eligible to participate in #ClinicalTrial EAA181/EQUATE. Learn more here: https://t.co/Ny8oyGFFbQ cc: @myelomaMD, @mtmdphd

[ECOG-ACRIN Cancer Research Group @eaonc]

.@michael_lidsky of @DukeSurgOnc and @DukeCancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: https://t.co/xBChV6GALe cc: @CCAlliance, @FightCRC, @NCCRTnews

[ECOG-ACRIN Cancer Research Group @eaonc]

.@MonikaJoshimd and @PGrivasMDPhD are leading #ClinicalTrial EA8231, a phase 3 randomized trial comparing the effectiveness of pembrolizumab and sacituzumab govitecan to standard-of-care chemo in patients with advanced #UrothelialCancer. https://t.co/pAPr7iuYmR

[ECOG-ACRIN Cancer Research Group @eaonc]

Help potentially improve the future of #HeadAndNeckCancer treatment. Take part in clinical study EA3191 for patients with squamous cell carcinoma of the head and neck (#HNSCC) that has come back. Learn more: https://t.co/0liEjdhnwI #HNCA

[ECOG-ACRIN Cancer Research Group @eaonc]

cc: @PanCAN, @SeenaMagowitz

[ECOG-ACRIN Cancer Research Group @eaonc]

This #NationalCancerSurvivorsMonth, we're celebrating survivors like Steven Merlin, who turned a #PancreaticCancer diagnosis into a story of hope. Through self-advocacy & participation in a clinical trial, Steven beat the odds & now helps others. More: https://t.co/4duVuPDqyE

[ECOG-ACRIN Cancer Research Group @eaonc]

In #ClinicalTrial EA7222, investigators are testing doxorubicin plus pembrolizumab vs. doxorubicin alone for patients with dedifferentiated #liposarcoma & undifferentiated pleomorphic #sarcoma. For more information: https://t.co/KtdZ47T1GZ #sarcomaawareness

[ECOG-ACRIN Cancer Research Group @eaonc]

#ClinicalTrial EA6244, led by @YanaNajjarMD of @UPMCHillmanCC, is testing a less invasive treatment approach for older adults with early-stage #melanoma. Learn more: https://t.co/w8gx60ULqd

[ECOG-ACRIN Cancer Research Group @eaonc]

The #ComboMATCH Study, led by researchers from @StanfordCancer, @MDAndersonNews, & @theNCI, is testing new combinations of anti-cancer drugs, based on characteristics found in patients’ tumors or blood. Learn more: https://t.co/00rdMtEMUk #PrecisionMedicine

[ECOG-ACRIN Cancer Research Group @eaonc]

.@eaonc Image Analytics Working Group Chair Dr. Elizabeth McDonald discusses results from a retrospective study showing that GLP-1 treatment was associated w/ a significantly lower incidence of #BreastCancer. Next step? A clinical trial. Watch the video: https://t.co/VSkyq2uDRh

[ECOG-ACRIN Cancer Research Group @eaonc]

Patients with aggressive B-cell #Lymphoma that has recurred or is resistant to treatment may be eligible to participate in #ClinicalTrial EA4231. Learn more here: https://t.co/hfbZzO89Q7 cc: @MelanicjMD, @theNCI, @UVACancerCenter

[ECOG-ACRIN Cancer Research Group @eaonc]

Urothelial cancer is the most common type of #bladdercancer. The EA8192 study is evaluating durvalumab and chemotherapy for patients with high grade upper tract urothelial cancer prior to nephroureterectomy. https://t.co/4dphxuN1s4 cc: @BladderCancerUS @JCensits @PGrivasMDPhD

[ECOG-ACRIN Cancer Research Group @eaonc]

The #BreastCancer study EA1242/RxFINE-Low is testing whether #HormoneTherapy plus ribociclib, without #Chemotherapy, is as effective as standard treatment that includes chemotherapy. Learn more: https://t.co/zrl0sIMaYa #BCSM #BreastCancerAwareness

[ECOG-ACRIN Cancer Research Group @eaonc]

#ClinicalTrial EA5221/ACHIEVE, led by Dr. Megan Baumgart of @URMC_DeptMed & @WilmotCancer, aims to help older patients with #LungCancer live longer while also maintaining a good quality of life. Learn more: https://t.co/4iFs1j4lU7 #NSCLC #LCSM

[ECOG-ACRIN Cancer Research Group @eaonc]

Congratulations to @HwakeleeMD, on being named a 2026 Giant of Cancer Care in Thoracic Malignancies 👏 A well-deserved recognition of her leadership in advancing #LungCancer research and improving patient outcomes. Learn more: https://t.co/YdwbQjD7tG

[Vincent Rajkumar @VincentRK]

Chairs @ALLIANCE_org @SWOG @EAONC myeloma committees.
IMWG meeting.

@szusmani @DoctorAKrishnan @VincentRK

[ECOG-ACRIN Cancer Research Group @eaonc]

Can patients with high-risk retroperitoneal #sarcoma benefit from neoadjuvant chemotherapy? The international EA7211/STRASS 2 #ClinicalTrial, led in the US by @kencardonaMD, aims to find out. Learn more: https://t.co/vMkhLxk8Qy #leiomyosarcoma #liposarcoma cc: @EORTC